Financhill
Back

State Street SPDR S&P Telecom ETF Vs. Oruka Therapeutics, Inc. Industry Stock Comparison

Buy
89

XTL
State Street SPDR S&P Telecom ETF

Last Price:
$156.77
Seasonality Move:
0.59%
Sell
40

ORKA
Oruka Therapeutics, Inc.

Last Price:
$31.98
Seasonality Move:
-10.99%
Buy
89
State Street SPDR S&P Telecom ETF (XTL) is a Buy

Is State Street SPDR S&P Telecom ETF a Buy, Sell or Hold?

  • The current State Street SPDR S&P Telecom ETF [XTL] share price is $156.89. The Score for XTL is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
  • XTL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
40
Oruka Therapeutics, Inc. (ORKA) is a Sell

Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XTL Stock Price Chart

What is State Street SPDR S&P Telecom ETF's stock price today?

  • The State Street SPDR S&P Telecom ETF share price today is $156.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XTL is experiencing buying pressure, which is a positive indicator for future bullish movement.

ORKA Stock Price Chart

What is Oruka Therapeutics, Inc.'s stock price today?

  • The Oruka Therapeutics, Inc. share price today is $31.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.

XTL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 33.71 Buy
Relative Strength Index (14 RSI): 60.34 Buy
Chaikin Money Flow: 23000 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (140.25 - 153.69) Buy
Bollinger Bands (100): (131.73 - 150.97) Buy

ORKA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.74 Buy
Relative Strength Index (14 RSI): 61.53 Buy
Chaikin Money Flow: 394649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.23 - 31.09) Buy
Bollinger Bands (100): (15.89 - 28.91) Buy

XTL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 151.38 Buy
20-day SMA: 149.5 Buy
50-day SMA: 147.89 Buy
200-day SMA: 123.46 Buy
8-day EMA: 96.01 Buy
20-day EMA: 49.68 Buy
50-day EMA: 22.22 Buy
200-day EMA: 5.89 Buy

ORKA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.97 Buy
20-day SMA: 30.06 Buy
50-day SMA: 28.52 Buy
200-day SMA: 16.89 Buy
8-day EMA: 30.34 Buy
20-day EMA: 29.78 Buy
50-day EMA: 27.54 Buy
200-day EMA: 21.05 Buy

State Street SPDR S&P Telecom ETF Earnings Growth & XTL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.

State Street SPDR S&P Telecom ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oruka Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):